Skip to Main Content

Go to Main Navigation

Horizon Discovery Biosciences Limited

Year Established:
Waterbeach, Cambridge, , GB
Company Type:
Mid-Sized Business (10-100M TTM Revenue)

Horizon Discovery is focused on commercializing the application of gene editing and gene modulation to accelerate scientific innovation and biopharmaceutical drug development.

Built upon decades of experience engineering cell lines, RNA synthesis, and bioinformatic design, we have created a unique portfolio of reagents and services that empower researchers to push their work forward with data generated from cell models. Whether users want to run the experiments in their labs or utilize our services group for cell line engineering or genomic screening projects, Horizon can support it.

Highlights of the reagent portfolio include gene editing solutions using CRISPR, and gene modulation technologies such as RNAi, CRISPRi, and CRISPRa. These enable almost any gene to be edited, or its function modulated. Horizon also offers catalog knockout cell lines, bioproduction platforms, molecular reference standards.

On the contract research front, Horizon’s service group supports researchers with cell line engineering, functional genomic screening, high-throughput immuno-oncology assays, compound profiling, drug combination screening, using CRISPR, or siRNA for a variety of cell-based assays.

Site Badges
Horizon Discovery Biosciences Limited
8100 Cambridge Research Park Waterbeach, Cambridge, , CB25 9TL United Kingdom
Horizon Discovery
5 Campus-Vienna-Biocenter Wien, Wien, 1030 Austria
Horizon Discovery
Cambridge, MA, 02142 United States

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service